Global Companion Animal Drugs Market: Share, Size, Growth, Opportunities, and Forecast 2020-2027

 

Companion Animal Drugs Market

Cats and dogs, which are domesticated and typically kept in or close to the home of the owner or person caring for them, are the most common types of companion animals. Animals kept as pets or as companions do not include farm animals or grazing animals like sheep and cattle.

Any dog, cat, or other domesticated animal owned by a person for companionship, security, hunting, herding, or assistance with a physical disability is considered a companion animal. However, any animal raised on a farm or ranch and used or intended for use as food is not considered a companion animal.

Among other things, a companion animal veterinarian administers medication to animals during operations, to treat injuries, and to identify various illnesses.

When receiving long-term treatment for a chronic ailment, Companion Animal Drugs Market experience stress and are challenging for their owners to handle. Through the use of medicated food supplements, these companion animal medications assist the growth and development of pets and enhance the nutritional content of the diet.

The Companion Animal Drugs Market is expanding as a result of factors such as increased zoonotic disease prevalence, rising availability and adoption of pet health insurance, and growing public awareness of the therapeutic use of various medications.

Globally, there is a growing trend to overfeed pets, which contributes to their rising obesity. This has had a negative effect on pets' health, making them more prone to illness, which is anticipated to increase demand for medications for companion animals.

One of the main drivers of Companion Animal Drugs Market expansion is the rising adoption of pets due to urbanization and the rise in the number of nuclear households. Expanding animal health awareness and rising pet insurance demand, particularly in developed nations, will support market growth. The need for companion animal medications is being driven by the ongoing increase in the number of diseases affecting animals. The global rise in zoonotic and food-borne diseases is another factor contributing to the industrial boom.

Drugs for Companion Animals: Global Market Analysis

Zoetis Inc., Merck & Co., Inc., Bayer AG, Eli Lilly & Co., Sanofi (Merial), Ceva Santé Animal, Virbac Animal Health, and Boehringer Ingelheim GmbH are significant market participants in the companion animal medicine industry.

Comments